In Vitro Diagnostics (IVD) Quality Control Market to Surpass with CAGR of 3.8% and Garner Revenue of $ 1,065.3 million.
(I-BusinessNews.Com, April 07, 2021 ) As per the report titled as “In Vitro Diagnostics (IVD) Quality Control Market–Global Opportunity Analysis and Industry Forecast (2017-2022)”, the global IVD quality controls market will grow at a CAGR of 3.8% during the forecast period to reach USD 1,065.3 million by 2022. The global In Vitro Diagnostics Quality Controls Market is driven by the increasing number of accredited clinical laboratories, growing demand for external quality assessment (EQA) support, and increasing mandates from regulatory & accreditation bodies on the use of quality controls. However, additional costs burden associated with quality controls on laboratories, unfavorable reimbursement scenario for IVD tests, and lack of mandatory regulations for clinical laboratory accreditation in many emerging countries is expected to restrain the growth of this market to a certain extent.
The global IVD quality controls market is majorly segmented by product type, application, end user, manufacturer type, and geography. Based on product type, the IVD quality controls market is majorly segmented into quality controls, data management software, and external quality assurance services. Quality Controls segment held the largest share in the global IVD quality controls market in 2016, owing to the increasing adoption of control materials with high stability to check the accuracy & precession of laboratory testing process and IVD tests results.
Based on application, the IVD quality controls market is majorly segmented into clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation/hemostasis, and others. The immunoassay segment accounted for the largest share of the global IVD quality controls market in 2016 and is also expected to continue its dominance during the forecast period. The large share of this segment is attributed to the higher adoption of high sensitive and cost-effective immunoassay tests for the diagnosis of increasing infectious diseases and relatively increased demand for multi-analyte immunoassay controls to ensure the accuracy & reliability of immunoassay test menus.
On the basis of end user, the In Vitro Diagnostics Quality Controls Market is majorly segmented into hospitals, clinical/ reference laboratories, research & academic institutes, and others. Hospitals segment held the largest share in the global IVD quality controls market in 2016. The largest share of this segment is mainly attributed to the large share of diagnostics tests performed in the hospital attached laboratories and relatively higher demand for quality controls in these healthcare settings to ensure the accuracy and reliability of IVD test results of the patients.
Based on manufacturer type, the IVD quality controls market is majorly segmented into IVD instrument manufacturers and third party quality control manufacturers.Third party quality control manufacturers commanded the largest share in the global IVD quality controls market in 2016. The largest share of this segment is attributed to the increasing demand for multi-analyte third party controls to obtain an unbiased opinion on the analytical performance of the laboratory.
Based on geography, this market is majorly segmented into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America holds the major share in the global IVD quality controls market, followed by Europe and Asia-Pacific region.The major share of North America is mainly attributed to the rising number of accredited laboratories, stringent rules and regulations on quality assurance in the region, higher adoption of innovative multi-analyte third party controls and related products & services, and well-established healthcare system & distribution channels in the U.S. However, Asia-Pacific region is projected to show lucrative growth potential for the In Vitro Diagnostics Quality Controls Market during the analysis period, owing to the significantly growing IVD industry in the region with rising demand for early diagnosis from large patient population in Asia, rising number of accredited laboratories, increasing number of hospitals and clinical pathologies, increasing healthcare spending, and improving healthcare infrastructure in the region.
The major players operating in the global In Vitro Diagnostics Quality Controls Market are Randox Laboratories Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Technopath Clinical Diagnostics (Ireland), SeraCare Life Sciences Inc. (U.S.), Merck KGaA (Germany), Maine Molecular Quality Controls, Inc. (U.S.), Sero AS (Norway), Eurotrol B.V. (The Netherlands), Omega Diagnostic Group PLC (U.K.), Fortress Diagnostic Limited (U.K.), Sun Diagnostics, LLC. (U.S.), Siemens AG (Germany), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Helena Biosciences Europe (U.K.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), ZeptoMetrix Corporation (U.S.), and Becton, Dickinson and Company (U.S.).
Which are the high growth market segments in terms of product type, application, end user, manufacturer type, and regions/countries?
What is the historical market for IVD quality control products and services across the globe?
What are the market forecasts and estimates for the period 2015-2022?
What are the major drivers, restrains, and trends in the global IVD quality controls market?
Who are the major players in the global IVD quality controls market and what share of the market do they hold?
Who are the major players in various countries and what share of the market do they hold?
What are the recent developments in the global IVD quality controls market?
What are the geographical trends and high growth regions/ countries?
Who are the local emerging players in the global IVD quality controls market and how do they compete with the global players?
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including: